STRADA Polyclonal Antibody

RD252195A
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetSTRADA
Overview
- SupplierReddot Biotech
- Product NameSTRADA Polyclonal Antibody
- Delivery Days Customer5
- ApplicationsELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1.5 mg/ml
- ConjugateUnconjugated
- Gene ID92335
- Target nameSTRADA
- Target descriptionSTE20 related adaptor alpha
- Target synonymsLYK5; NY-BR-96; PMSE; protein kinase LYK5; serologically defined breast cancer antigen NY-BR-96; STE20-like pseudokinase; STE20-related kinase adapter protein alpha; STE20-related kinase adaptor alpha; Stlk; STRAD; STRAD alpha
- HostRabbit
- IsotypeIgG
- Scientific DescriptionThe protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a pseudokinase. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known.
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C
- UNSPSC12352203